Low Dose Radiotherapy for Osteoarthritis

For several decades, low dose radiotherapy (LDRT) has been used in the treatment of osteoarthritis (OA) with significant success. Low dose radiotherapy has been established as an effective therapeutic alternative for patients with OA evidenced by multiple clinical trials with symptomatic pain relief shown in 70-90% of all irradiated patients. Given its low toxicity profile, proven effectiveness, non-invasive approach, and non-interference with other therapies, LDRT offers an excellent therapeutic option for refractory OA patients. In this activity, we provide an overview of literature and techniques to effectively deliver LDRT for OA.

Presenters: Austin Dove, MD and Austin Kirschner, MD, PhD
Moderator: Bobby N. Koneru, MD, FASTRO

This session was originally presented and recorded as a live webinar on September 24, 2024.

Target Audience

This activity is designed to meet the interests of radiation oncologists.

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

  • Articulate the evidence showing benefit of low dose radiotherapy (LDRT) for osteoarthritis as well as limitations.
  • Identify appropriate patients who might benefit from LDRT and identify strategies for educating referring providers to develop thriving service line.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
Course opens: 
07/22/2024
Course expires: 
10/09/2026
Cost:
$0.00
Part of: 
Expanding the Scope of Radiation Therapy for Nonmalignant Diseases
Rating: 
0
  • Austin Dove, MD is employed by Tennessee Oncology.
  • Austin Kirschner, MD, PhD is employed by Vanderbilt University.
  • Bobby N. Koneru, MD, FASTRO is employed by FHN Memorial Hospital and Loyola University Stritch School of Medicine. Dr. Koneru serves on the Clinical Advisory Board of the International Organisation for Radiotherapy for Benign Conditions

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.